SkinCure Oncology

Founded with a mission to provide comprehensive support for superficial radiation therapy (SRT) in skin cancer treatment, SkinCure Oncology focuses on offering an alternative to traditional Mohs surgery. The company aims to enhance patient care and expand treatment options through the use of image-guided SRT technology. Their services are designed to support dermatology practices in integrating this advanced treatment method, thereby improving patient outcomes and practice growth.

SkinCure Oncology has established itself as a significant player in the dermatology field by partnering with numerous medical practices across the country. Notable investors and affiliated individuals include experts in oncology and dermatology who advocate for innovative cancer treatment methods. The company’s key achievements include widespread adoption of their SRT technology, which has positively impacted patient care by providing a non-invasive alternative to surgery. Overall, SkinCure Oncology has made a substantial impact on the skin cancer treatment landscape by promoting safer, more effective therapeutic options.